Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer Patients

NCT03190239 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped abandon

Conditions

Advanced Non-squamous Non-small-cell Lung Cancer

Interventions

DRUG: Apatinib
DRUG: Pemetrexed

Sponsor

Xinqiao Hospital of Chongqing